Page 2 - Tim Mayleben News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ESPERION Appoints Sheldon Koenig as President and CEO May 17, 2021 09:01 ET | Source: Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. Ann Arbor, Michigan, UNITED STATES -- Mr. Koenig has 30 years of commercial and operational experience as an accomplished leader in the cardiovascular space;  previously served as ESPERION COO -- -- Succeeds Tim Mayleben, who served as President and CEO for almost a decade and will continue to serve as a senior advisor – ANN ARBOR, Mich., May 17, 2021 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR), today ann...

Esperion Therapeutics Inc. has appointed Sheldon Koenig to be its new president and CEO, succeeding Tim Mayleben, who has served in the role for a decade.The Ann Arbor-based pharmaceutical company said in a Monday morning news release that Koenig's appointment as the top executive for the company…

Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. Benjamin Church -- Head, Corporate Communications & Investor Relations Thank you, operator. Good afternoon and welcome to Esperion's First Quarter 2021 Financial Results and Company Update Conference Call. I'm Ben Church, and I'm responsible for Investor Relations and Corporate Communications here at Esperion. With me on today's call are Tim Mayleben, Presid...

Esperion strikes deals that add $80 million to cash pile Esperion strikes deals that add $80 million to cash pile Esperion markets one of its approved cholesterol drugs as Nexletol in the U.S. Two new cash-generating deals were announced Monday by drugmaker Esperion Therapeutics Inc. as it works to commercialize its cholesterol-lowering drugs around the world. The Ann Arbor-based cholesterol-focused biotechnology company said it had reached a deal with Japanese pharma firm Daiichi Sankyo Company Ltd. to distribute its drugs in several countries in Asia with possible expansion to countries in ...

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Esperion Therapeutics Inc (NASDAQ: ESPR) Popular Searches Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today's conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. This article is a transcript of this conference call produced for...